{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:25:33Z","timestamp":1782512733854,"version":"3.54.5"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"DST-INSPIRE","award":["IF 150104"],"award-info":[{"award-number":["IF 150104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Pept Res Ther"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10989-020-10072-0","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T16:51:46Z","timestamp":1589820706000},"page":"149-168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["Antiviral Peptides: Identification and Validation"],"prefix":"10.1007","volume":"27","author":[{"given":"Garima","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9306-2600","authenticated-orcid":false,"given":"Reema","family":"Gabrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"key":"10072_CR1","doi-asserted-by":"publisher","first-page":"14753","DOI":"10.1038\/srep14753","volume":"5","author":"M Aggarwal","year":"2015","unstructured":"Aggarwal M, Sharma R, Kumar P, Parida M, Tomar S (2015) Kinetic characterization of trans-proteolytic activity of Chikungunya virus capsid protease and development of a FRET-based HTS assay. Sci Rep 5:14753. https:\/\/doi.org\/10.1038\/srep14753","journal-title":"Sci Rep"},{"key":"10072_CR2","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3390\/v11080704","volume":"11","author":"A Ahmed","year":"2019","unstructured":"Ahmed A, Siman-Tov G, Hall G, Bhalla N, Narayanan A (2019a) Human antimicrobial peptides as therapeutics for viral infections. Viruses 11:704. https:\/\/doi.org\/10.3390\/v11080704","journal-title":"Viruses"},{"key":"10072_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.antiviral.2019.02.002","volume":"164","author":"A Ahmed","year":"2019","unstructured":"Ahmed A, Siman-Tov G, Keck F, Kortchak S, Bakovic A, Risner K, Lu TK, Bhalla N, de la Fuente-Nunez C, Narayanan A (2019b) Human cathelicidin peptide LL-37 as a therapeutic antiviral targeting Venezuelan equine encephalitis virus infections. Antiviral Res 164:61\u201369. https:\/\/doi.org\/10.1016\/j.antiviral.2019.02.002","journal-title":"Antiviral Res"},{"key":"10072_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.peptides.2017.04.002","volume":"92","author":"K Alagarasu","year":"2017","unstructured":"Alagarasu K, Patil PS, Shil P, Seervi M, Kakade MB, Tillu H, Salunke A (2017) In-vitro effect of human cathelicidin antimicrobial peptide LL-37 on dengue virus type 2. Peptides 92:23\u201330. https:\/\/doi.org\/10.1016\/j.peptides.2017.04.002","journal-title":"Peptides"},{"key":"10072_CR5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ijantimicag.2003.07.022","volume":"23","author":"VC Albiol Matanic","year":"2004","unstructured":"Albiol Matanic VC, Castilla V (2004) Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus. Int J Antimicrob Agents 23:382\u2013389. https:\/\/doi.org\/10.1016\/j.ijantimicag.2003.07.022","journal-title":"Int J Antimicrob Agents"},{"key":"10072_CR6","volume-title":"Advances in protein chemistry","author":"R Ali","year":"2013","unstructured":"Ali R, Rani R, Kumar S (2013) New peptide based therapeutic approaches. In: Ashraf GMd, Sheikh IA (eds) Advances in protein chemistry. OMICS Group eBooks, Jeddah"},{"key":"10072_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/S0042-6822(03)00313-1","volume":"313","author":"A Amin","year":"2003","unstructured":"Amin A, Zaccardi J, Mullen S, Olland S, Orlowski M, Feld B, Labonte P, Mak P (2003) Identification of constrained peptides that bind to and preferentially inhibit the activity of the hepatitis C viral RNA-dependent RNA polymerase. Virology 313:158\u2013169. https:\/\/doi.org\/10.1016\/S0042-6822(03)00313-1","journal-title":"Virology"},{"key":"10072_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11262-005-2203-1","volume":"31","author":"TQ An","year":"2005","unstructured":"An TQ, Zhou YJ, Qiu HJ, Tong GZ, Wang YF, Liu JX, Yang JY (2005) Identification of a Novel B cell epitope on the nucleocapsid protein of porcine reproductive and respiratory syndrome virus by phage display. Virus Genes 31:81\u201387. https:\/\/doi.org\/10.1007\/s11262-005-2203-1","journal-title":"Virus Genes"},{"key":"10072_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/s0166-3542(01)00146-2","volume":"51","author":"JH Andersen","year":"2001","unstructured":"Andersen JH, Osbakk SA, Vorland LH et al (2001) Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res 51:141\u2013149. https:\/\/doi.org\/10.1016\/s0166-3542(01)00146-2","journal-title":"Antiviral Res"},{"key":"10072_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3390\/md20080027","volume":"6","author":"CD Andjelic","year":"2008","unstructured":"Andjelic CD, Planelles V, Barrows LR (2008) Characterizing the anti-HIV activity of Papuamide A. Mar Drugs 6:528\u2013549. https:\/\/doi.org\/10.3390\/md20080027","journal-title":"Mar Drugs"},{"key":"10072_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13041-019-0482-z","volume":"12","author":"V Avdoshina","year":"2019","unstructured":"Avdoshina V, Taraballi F, Tasciotti E, Uren A, Mocchetti I (2019) Helix-A peptide prevents gp120-mediated neuronal loss. Mol Brain 12:61. https:\/\/doi.org\/10.1186\/s13041-019-0482-z","journal-title":"Mol Brain"},{"key":"10072_CR12","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.bbamem.2014.04.015","volume":"1838","author":"H Badani","year":"2014","unstructured":"Badani H, Garry RF, Wimley WC (2014) Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity. Biochim Biophys Acta Biomembr 1838:2180\u20132197. https:\/\/doi.org\/10.1016\/j.bbamem.2014.04.015","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"10072_CR13","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1128\/JVI.01840-06","volume":"81","author":"F Bai","year":"2007","unstructured":"Bai F, Town T, Pradhan D, Cox J, Ledizet M, Anderson JF, Flavell RA, Krueger JK, Koski RA, Fikrig E (2007) Antiviral peptides targeting the West Nile virus envelope protein. J Virol 81:2047\u20132055. https:\/\/doi.org\/10.1128\/JVI.01840-06","journal-title":"J Virol"},{"key":"10072_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0025333","volume":"6","author":"PG Barlow","year":"2011","unstructured":"Barlow PG, Svoboda P, Mackellar A, Nash AA, York IA, Pohl J, Davidson DJ, Donis RO (2011) Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37. PLoS ONE 6:1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0025333","journal-title":"PLoS ONE"},{"key":"10072_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/jmv.23450","volume":"85","author":"I Bergaoui","year":"2013","unstructured":"Bergaoui I, Zairi A, Tangy F, Aouni M, Selmi B, Hani K (2013) In vitro antiviral activity of dermaseptin S4 and derivatives from amphibian skin against herpes simplex virus type 2. J Med Virol 85:272\u2013281. https:\/\/doi.org\/10.1002\/jmv.23450","journal-title":"J Med Virol"},{"key":"10072_CR16","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jhep.2016.04.016","volume":"65","author":"P Bogomolov","year":"2016","unstructured":"Bogomolov P, Alexandrov A, Voronkova N, Macievich M, Kokina K, Petrachenkova M, Lehr T, Lempp FA, Wedemeyer H, Haag M, Schwab M (2016) Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib\/IIa study. J Hepatol 65:490\u2013498. https:\/\/doi.org\/10.1016\/j.jhep.2016.04.016","journal-title":"J Hepatol"},{"key":"10072_CR17","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1128\/aac.00854-13","volume":"57","author":"EM Borst","year":"2013","unstructured":"Borst EM, St\u00e4ndker L, Wagner K et al (2013) A peptide inhibitor of cytomegalovirus infection from human hemofiltrate. Antimicrob Agents Chemother 57:4751\u20134760. https:\/\/doi.org\/10.1128\/aac.00854-13","journal-title":"Antimicrob Agents Chemother"},{"key":"10072_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.0105-2896.2004.0124.x","volume":"198","author":"P Bulet","year":"2004","unstructured":"Bulet P, St\u00f6cklin R, Menin L (2004) Anti-microbial peptides: from invertebrates to vertebrates. Immunol Rev 198:169\u2013184. https:\/\/doi.org\/10.1111\/j.0105-2896.2004.0124.x","journal-title":"Immunol Rev"},{"key":"10072_CR19","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.phymed.2007.07.059","volume":"15","author":"I Camargo Filho","year":"2008","unstructured":"Camargo Filho I, Cortez DAG, Ueda-Nakamura T, Nakamura CV, Dias Filho BP (2008) Antiviral activity and mode of action of a peptide isolated from Sorghum bicolor. Phytomedicine 15:202\u2013208. https:\/\/doi.org\/10.1016\/j.phymed.2007.07.059","journal-title":"Phytomedicine"},{"key":"10072_CR20","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.mimet.2006.11.009","volume":"68","author":"J Cao","year":"2007","unstructured":"Cao J, Liao XL, Wu SM, Zhao P, Zhao LJ, Wu WB, Qi ZT (2007) Selection of a phage-displayed peptide recognized by monoclonal antibody directed blocking the site of hepatitis C virus E2 for human CD81. J Microbiol Methods 68:601\u2013604. https:\/\/doi.org\/10.1016\/j.mimet.2006.11.009","journal-title":"J Microbiol Methods"},{"key":"10072_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1590\/s0074-02762007005000028","volume":"102","author":"MC Carriel-Gomes","year":"2007","unstructured":"Carriel-Gomes MC, Kratz JM, Barracco MA, Bach\u00e9re E, Barardi CR, Sim\u00f5es CM (2007) In vitro antiviral activity of antimicrobial peptides against herpes simplex virus 1, adenovirus, and rotavirus. Mem Inst Oswaldo Cruz 102:469\u2013472. https:\/\/doi.org\/10.1590\/s0074-02762007005000028","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10072_CR22","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1099\/jgv.0.000849","volume":"98","author":"CAM Carvalho","year":"2017","unstructured":"Carvalho CAM, Casseb SMM, Gon\u00e7alves RB, Silva EV, Gomes AM, Vasconcelos PF (2017) Bovine lactoferrin activity against Chikungunya and Zika viruses. J Gen Virol 98:1749\u20131754. https:\/\/doi.org\/10.1099\/jgv.0.000849","journal-title":"J Gen Virol"},{"key":"10072_CR23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1590\/s1517-83822014000300043","volume":"45","author":"CC Castro","year":"2014","unstructured":"Castro CC, Sant'anna V, Vargas GD, Lima MD, Fischer G, Brandelli A, Motta AD, H\u00fcbner SD (2014) Antiviral activity of a Bacillus sp: P34 peptide against pathogenic viruses of domestic animals. Braz J Microbiol 45:1089\u20131094. https:\/\/doi.org\/10.1590\/s1517-83822014000300043","journal-title":"Braz J Microbiol"},{"key":"10072_CR24","doi-asserted-by":"publisher","first-page":"e20160668","DOI":"10.1590\/0103-8478cr20160668","volume":"47","author":"CC Castro","year":"2017","unstructured":"Castro CC, Silva DS, Costa GA, Fischer G, Vargas GD, Brandelli A, Lima MD, Motta AD, Hubner SD (2017) Activity of the antimicrobial peptide P34 against bovine alpha herpes virus type 1. Ci\u00eancia Rural 47:e20160668. https:\/\/doi.org\/10.1590\/0103-8478cr20160668","journal-title":"Ci\u00eancia Rural"},{"key":"10072_CR25","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1128\/aac.01357-09","volume":"54","author":"F Chen","year":"2010","unstructured":"Chen F, Zhao Y, Liu M, Li D, Wu H, Chen H, Zhu Y, Luo F, Zhong J, Zhou Y, Qi Z (2010) Functional selection of hepatitis C virus envelope E2-binding Peptide ligands by using ribosome display. Antimicrob Agents Chemother 54:3355\u20133364. https:\/\/doi.org\/10.1128\/aac.01357-09","journal-title":"Antimicrob Agents Chemother"},{"key":"10072_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0034947","volume":"7","author":"Y Chen","year":"2012","unstructured":"Chen Y, Cao L, Zhong M, Zhang Y, Han C, Li Q, Yang J, Zhou D, Shi W, He B, Liu F (2012) Anti-HIV-1 activity of a new scorpion venom peptide derivative Kn2-7. PLoS ONE 7:1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0034947","journal-title":"PLoS ONE"},{"key":"10072_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18091957","volume":"18","author":"JM Chen","year":"2017","unstructured":"Chen JM, Fan YC, Lin JW, Chen YY, Hsu WL, Chiou SS (2017) Bovine lactoferrin inhibits dengue virus infectivity by interacting with heparan sulfate, low-density lipoprotein receptor, and DC-SIGN. Int J Mol Sci 18:1\u201313. https:\/\/doi.org\/10.3390\/ijms18091957","journal-title":"Int J Mol Sci"},{"key":"10072_CR28","doi-asserted-by":"publisher","first-page":"12628","DOI":"10.1073\/pnas.192301899","volume":"99","author":"S Chernysh","year":"2002","unstructured":"Chernysh S, Kim SI, Bekker G, Pleskach VA, Filatova NA, Anikin VB, Platonov VG, Bulet P (2002) Antiviral and antitumor peptides from insects. Proc Natl Acad Sci 99:12628\u201312632. https:\/\/doi.org\/10.1073\/pnas.192301899","journal-title":"Proc Natl Acad Sci"},{"key":"10072_CR29","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.7150\/ijms.21875","volume":"14","author":"MF Chew","year":"2017","unstructured":"Chew MF, Poh KS, Poh CL (2017) Peptides as therapeutic agents for dengue virus. Int J Med Sci 14:1342\u20131359. https:\/\/doi.org\/10.7150\/ijms.21875","journal-title":"Int J Med Sci"},{"key":"10072_CR30","doi-asserted-by":"publisher","first-page":"e0120847","DOI":"10.1371\/journal.pone.0120847","volume":"10","author":"AN Chikaev","year":"2015","unstructured":"Chikaev AN, Bakulina AY, Burdick RC, Karpenko LI, Pathak VK, Ilyichev AA (2015) Selection of Peptide Mimics of HIV-1 Epitope Recognized by Neutralizing Antibody VRC01. PLoS ONE 10:e0120847. https:\/\/doi.org\/10.1371\/journal.pone.0120847","journal-title":"PLoS ONE"},{"key":"10072_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-61779-379-0_16","volume":"805","author":"SW Cotten","year":"2012","unstructured":"Cotten SW, Zou J, Wang R, Huang BC, Liu R (2012) mRNA display-based selections using synthetic peptide and natural protein libraries. Methods Mol Biol 805:287\u2013297. https:\/\/doi.org\/10.1007\/978-1-61779-379-0_16","journal-title":"Methods Mol Biol"},{"key":"10072_CR32","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1365-2230.2012.04305.x","volume":"37","author":"LR Crack","year":"2012","unstructured":"Crack LR, Jones L, Malavige GN, Patel V, Ogg GS (2012) Human antimicrobial peptides LL-37 and human \u03b2-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus. Clin Exp Dermatol 37:534\u2013543. https:\/\/doi.org\/10.1111\/j.1365-2230.2012.04305.x","journal-title":"Clin Exp Dermatol"},{"key":"10072_CR33","doi-asserted-by":"publisher","first-page":"1827341","DOI":"10.1155\/2017\/1827341","volume":"2017","author":"C de la Guardia","year":"2017","unstructured":"de la Guardia C, Quijada M, Lleonart R (2017) Phage-displayed peptides selected to bind envelope glycoprotein show antiviral activity against dengue virus serotype 2. Adv Virol 2017:1827341. https:\/\/doi.org\/10.1155\/2017\/1827341","journal-title":"Adv Virol"},{"key":"10072_CR34","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1128\/jvi.01270-06","volume":"81","author":"Q Deng","year":"2007","unstructured":"Deng Q, Zhai JW, Michel ML, Zhang J, Qin J, Kong YY, Zhang XX, Budkowska A, Tiollais P, Wang Y, Xie YH (2007) Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site. J Virol 81:4244\u20134254. https:\/\/doi.org\/10.1128\/jvi.01270-06","journal-title":"J Virol"},{"key":"10072_CR35","doi-asserted-by":"publisher","first-page":"13097","DOI":"10.1021\/bi049385e","volume":"43","author":"C Desjobert","year":"2004","unstructured":"Desjobert C, de Soultrait VR, Faure A, Parissi V, Litvak S, Tarrago-Litvak L, Fournier M (2004) Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase. Biochemistry 43:13097\u201313105. https:\/\/doi.org\/10.1021\/bi049385e","journal-title":"Biochemistry"},{"key":"10072_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2174\/0929866526666190925152957","volume":"27","author":"M Divyashree","year":"2020","unstructured":"Divyashree M, Mani MK, Reddy D, Kumavath R, Ghosh P, Azevedo V, Barh D (2020) Clinical applications of antimicrobial peptides (AMPs): where do we stand now? Protein Pept Lett 27:120\u2013134. https:\/\/doi.org\/10.2174\/0929866526666190925152957","journal-title":"Protein Pept Lett"},{"key":"10072_CR37","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1021\/np700718p","volume":"71","author":"MS Donia","year":"2008","unstructured":"Donia MS, Wang B, Dunbar DC, Desai PV, Patny A, Avery M, Hamann MT (2008) Mollamides B and C, Cyclic Hexapeptides from the Indonesian Tunicate Didemnum molle. J Nat Prod 71:941\u2013945. https:\/\/doi.org\/10.1021\/np700718p","journal-title":"J Nat Prod"},{"key":"10072_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/978-1-60761-944-4_21","volume":"687","author":"B Dreier","year":"2011","unstructured":"Dreier B, Pluckthun A (2011) Ribosome display: a technology for selecting and evolving proteins from large libraries. Methods Mol Biol 687:283\u2013306. https:\/\/doi.org\/10.1007\/978-1-60761-944-4_21","journal-title":"Methods Mol Biol"},{"key":"10072_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3390\/md17020087","volume":"17","author":"A Falco","year":"2019","unstructured":"Falco A, Medina-Gali R, Poveda J, Bello-Perez M, Novoa B, Encinar JA (2019) Antiviral activity of a Turbot (Scophthalmus maximus) NK-lysin peptide by inhibition of low-pH virus-induced membrane fusion. Mar Drugs 17:87. https:\/\/doi.org\/10.3390\/md17020087","journal-title":"Mar Drugs"},{"key":"10072_CR40","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1128\/JVI.73.7.5795-5802.1999","volume":"73","author":"M Ferrer","year":"1999","unstructured":"Ferrer M, Harrison SC (1999) Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries. J Virol 73:5795\u20135802","journal-title":"J Virol"},{"key":"10072_CR41","doi-asserted-by":"publisher","first-page":"295719","DOI":"10.1155\/2012\/295719","volume":"2012","author":"K Fukunaga","year":"2012","unstructured":"Fukunaga K, Taki M (2012) Practical tips for construction of custom peptide libraries and affinity selection by using commercially available phage display cloning systems. J Nucleic Acids 2012:295719. https:\/\/doi.org\/10.1155\/2012\/295719","journal-title":"J Nucleic Acids"},{"key":"10072_CR42","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/psc.2489","volume":"19","author":"S Galdiero","year":"2013","unstructured":"Galdiero S, Falanga A, Tarallo R, Russo L, Galdiero E, Cantisani M, Morelli G, Galdiero M (2013) Peptide inhibitors against herpes simplex virus infections. J Pept Sci 19:148\u2013158. https:\/\/doi.org\/10.1002\/psc.2489","journal-title":"J Pept Sci"},{"key":"10072_CR43","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.bmc.2009.12.026","volume":"18","author":"Y Gao","year":"2010","unstructured":"Gao Y, Cui T, Lam Y (2010) Synthesis and disulfide bond connectivity-activity studies of a kalata B1-inspired cyclopeptide against dengue NS2B-NS3 protease. Bioorganic Med Chem 18:1331\u20131336. https:\/\/doi.org\/10.1016\/j.bmc.2009.12.026","journal-title":"Bioorganic Med Chem"},{"key":"10072_CR44","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.2174\/138161210793292555","volume":"16","author":"L Gentilucci","year":"2010","unstructured":"Gentilucci L, De Marco R, Cerisoli L (2010) Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Curr Pharm Des 16:3185\u20133203. https:\/\/doi.org\/10.2174\/138161210793292555","journal-title":"Curr Pharm Des"},{"key":"10072_CR45","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/02713680590934111","volume":"30","author":"YJ Gordon","year":"2005","unstructured":"Gordon YJ, Huang LC, Romanowski EG et al (2005) Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr Eye Res 30:385\u2013394. https:\/\/doi.org\/10.1080\/02713680590934111","journal-title":"Curr Eye Res"},{"key":"10072_CR46","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ebiom.2015.06.021","volume":"2","author":"N Guo","year":"2015","unstructured":"Guo N, Duan H, Kachko A, Krause BW, Major ME, Krause PR (2015) Reverse engineering of vaccine antigens using high throughput sequencing enhanced mRNA display. EBioMedicine 2:859\u2013867. https:\/\/doi.org\/10.1016\/j.ebiom.2015.06.021","journal-title":"EBioMedicine"},{"key":"10072_CR47","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40259-013-0039-0","volume":"27","author":"E Gwyer Findlay","year":"2013","unstructured":"Gwyer Findlay E, Currie SM, Davidson DJ (2013) Cationic host defence peptides: potential as antiviral therapeutics. BioDrugs 27:479\u2013493. https:\/\/doi.org\/10.1007\/s40259-013-0039-0","journal-title":"BioDrugs"},{"issue":"5","key":"10072_CR48","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1128\/JVI.71.5.3879-3885.1997","volume":"71","author":"T Heiskanen","year":"1997","unstructured":"Heiskanen T, Lundkvist A, Vaheri A, Lankinen H (1997) Phage-displayed peptide targeting on the Puumala hantavirus neutralization site. J Virol 71(5):3879\u20133885","journal-title":"J Virol"},{"key":"10072_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1476-5381.2009.00057.x","volume":"157","author":"F Heitz","year":"2009","unstructured":"Heitz F, Morris MC, Divita G (2009) Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol 157:195\u2013206. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00057.x","journal-title":"Br J Pharmacol"},{"key":"10072_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1074\/jbc.m111.253393","volume":"286","author":"ST Henriques","year":"2011","unstructured":"Henriques ST, Huang YH, Rosengren KJ, Franquelim HG, Carvalho FA, Johnson A, Sonza S, Tachedjian G, Castanho MA, Daly NL, Craik DJ (2011) Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities. J Biol Chem 286:1\u201324. https:\/\/doi.org\/10.1074\/jbc.m111.253393","journal-title":"J Biol Chem"},{"key":"10072_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/jmv.10266","volume":"69","author":"KL Ho","year":"2003","unstructured":"Ho KL, Yusoff K, Seow HF, Tan WS (2003) Selection of high affinity ligands to hepatitis B core antigen from a phage-displayed cyclic peptide library. J Med Virol 69:27\u201332. https:\/\/doi.org\/10.1002\/jmv.10266","journal-title":"J Med Virol"},{"key":"10072_CR52","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.immuni.2017.03.018","volume":"46","author":"DJ Holthausen","year":"2017","unstructured":"Holthausen DJ, Lee SH, Kumar VT, Bouvier NM, Krammer F, Ellebedy AH, Wrammert J, Lowen AC, George S, Pillai MR, Jacob J (2017) An amphibian host defense peptide is virucidal for human H1 hemagglutinin bearing influenza viruses. Immunity 46:587\u2013595. https:\/\/doi.org\/10.1016\/j.immuni.2017.03.018","journal-title":"Immunity"},{"key":"10072_CR53","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1016\/j.biomaterials.2013.01.075","volume":"34","author":"W Hong","year":"2013","unstructured":"Hong W, Zhang R, Di Z, He Y, Zhao Z, Hu J, Wu Y, Li W, Cao Z (2013) Design of histidine-rich peptides with enhanced bioavailability and inhibitory activity against hepatitis C virus. Biomaterials 34:3511\u20133522. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.01.075","journal-title":"Biomaterials"},{"key":"10072_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2013.11.013","volume":"102","author":"W Hong","year":"2014","unstructured":"Hong W, Li T, Song Y, Zhang R, Zeng Z, Han S, Zhang X, Wu Y, Li W, Cao Z (2014) Inhibitory activity and mechanism of two scorpion venom peptides against herpes simplex virus type 1. Antiviral Res 102:1\u201310. https:\/\/doi.org\/10.1016\/j.antiviral.2013.11.013","journal-title":"Antiviral Res"},{"key":"10072_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3851\/imp2346","volume":"18","author":"JL Hood","year":"2013","unstructured":"Hood JL, Jallouk AP, Campbell N, Ratner L, Wickline SA (2013) Cytolytic nanoparticles attenuate HIV-1 infectivity. Antivir Ther 18:95\u2013103. https:\/\/doi.org\/10.3851\/imp2346","journal-title":"Antivir Ther"},{"key":"10072_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12917-017-1315-x","volume":"14","author":"P Hou","year":"2018","unstructured":"Hou P, Zhao G, He C, Wang H, He H (2018) Biopanning of polypeptides binding to bovine ephemeral fever virus G 1 protein from phage display peptide library. BMC Vet Res 14:3. https:\/\/doi.org\/10.1186\/s12917-017-1315-x","journal-title":"BMC Vet Res"},{"key":"10072_CR57","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jaci.2007.01.044","volume":"119","author":"MD Howell","year":"2007","unstructured":"Howell MD, Streib JE, Leung DYM (2007) Antiviral activity of human beta-defensin 3 against vaccinia virus. J Allergy Clin Immunol 119:1022\u20131025. https:\/\/doi.org\/10.1016\/j.jaci.2007.01.044","journal-title":"J Allergy Clin Immunol"},{"key":"10072_CR58","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12985-019-1199-4","volume":"16","author":"H Hu","year":"2019","unstructured":"Hu H, Guo N, Chen S, Guo X, Liu X, Ye S, Chai Q, Wang Y, Liu B, He Q (2019) Antiviral activity of Piscidin 1 against pseudorabies virus both in vitro and in vivo. Virol J 16:95. https:\/\/doi.org\/10.1186\/s12985-019-1199-4","journal-title":"Virol J"},{"key":"10072_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1432-1033.1980.tb05991.x","volume":"106","author":"D Hultmark","year":"2005","unstructured":"Hultmark D, Steiner H, Rasmuson T, Boman HG (2005) Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur J Biochem 106:7\u201316. https:\/\/doi.org\/10.1111\/j.1432-1033.1980.tb05991.x","journal-title":"Eur J Biochem"},{"key":"10072_CR60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/bip.20886","volume":"90","author":"DC Ireland","year":"2008","unstructured":"Ireland DC, Wang CKL, Wilson JA, Gustafson KR, Craik DJ (2008) Cyclotides as natural anti-HIV agents. Biopolym - Pept Sci Sect 90:51\u201360. https:\/\/doi.org\/10.1002\/bip.20886","journal-title":"Biopolym - Pept Sci Sect"},{"key":"10072_CR61","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.peptides.2005.01.003","volume":"26","author":"HW Jack","year":"2005","unstructured":"Jack HW, Tzi BN (2005) Sesquin, a potent defensin-like antimicrobial peptide from ground beans with inhibitory activities toward tumor cells and HIV-1 reverse transcriptase. Peptides 26:1120\u20131126. https:\/\/doi.org\/10.1016\/j.peptides.2005.01.003","journal-title":"Peptides"},{"key":"10072_CR62","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3390\/v1030939","volume":"1","author":"H Jenssen","year":"2009","unstructured":"Jenssen H (2009) Therapeutic approaches using host defence peptides to tackle herpes virus infections. Viruses 1:939\u2013964. https:\/\/doi.org\/10.3390\/v1030939","journal-title":"Viruses"},{"key":"10072_CR63","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/psc.1219","volume":"16","author":"M Kuczer","year":"2010","unstructured":"Kuczer M, Dziubasik K, Midak-Siewirska A, Zahorska R, Luczak M, Konopinska D (2010) Studies of insect peptides alloferon, Any-GS and their analogues. Synthesis and antiherpes activity. J Pept Sci 16:186\u2013189. https:\/\/doi.org\/10.1002\/psc.1219","journal-title":"J Pept Sci"},{"key":"10072_CR64","doi-asserted-by":"publisher","first-page":"e1952","DOI":"10.1002\/rmv.1952","volume":"27","author":"PKR Kumar","year":"2017","unstructured":"Kumar PKR (2017) Systematic screening of viral entry inhibitors using surface plasmon resonance. Rev Med Virol 27:e1952. https:\/\/doi.org\/10.1002\/rmv.1952","journal-title":"Rev Med Virol"},{"key":"10072_CR65","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1016\/j.bmc.2017.06.052","volume":"26","author":"JL Lau","year":"2018","unstructured":"Lau JL, Dunn MK (2018) Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorg Med Chem 26:2700\u20132707. https:\/\/doi.org\/10.1016\/j.bmc.2017.06.052","journal-title":"Bioorg Med Chem"},{"key":"10072_CR66","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3390\/ijms20102383","volume":"20","author":"AC Lee","year":"2019","unstructured":"Lee AC, Harris JL, Khanna KK, Hong JH (2019) A comprehensive review on current advances in peptide drug development and design. Int J Mol Sci 20:2383. https:\/\/doi.org\/10.3390\/ijms20102383","journal-title":"Int J Mol Sci"},{"key":"10072_CR67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00430-008-0100-7","volume":"198","author":"S Li","year":"2009","unstructured":"Li S, Zhou H, Huang G, Liu N (2009) Inhibition of HBV infection by bovine lactoferrin and iron, zinc-saturated lactoferrin. Med Microbiol Immunol 198:19\u201325. https:\/\/doi.org\/10.1007\/s00430-008-0100-7","journal-title":"Med Microbiol Immunol"},{"key":"10072_CR68","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.peptides.2011.05.015","volume":"32","author":"Q Li","year":"2011","unstructured":"Li Q, Zhao Z, Zhou D, Chen Y, Hong W, Cao L, Yang J, Zhang Y, Shi W, Cao Z, Wu Y (2011) Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS CoV and influenza H5N1 viruses. Peptides 32:1518\u20131525. https:\/\/doi.org\/10.1016\/j.peptides.2011.05.015","journal-title":"Peptides"},{"key":"10072_CR69","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1039\/c9md00252a","volume":"10","author":"S Linciano","year":"2019","unstructured":"Linciano S, Pluda S, Bacchin A, Angelini A (2019) Molecular evolution of peptides by yeast surface display technology. Med Chem Comm 10:1569\u20131580. https:\/\/doi.org\/10.1039\/c9md00252a","journal-title":"Med Chem Comm"},{"key":"10072_CR70","doi-asserted-by":"publisher","first-page":"15293","DOI":"10.1073\/pnas.0805837105","volume":"105","author":"A Litovchick","year":"2008","unstructured":"Litovchick A, Szostak JW (2008) Selection of cyclic peptide aptamers to HCV IRES RNA using mRNA display. Proc Natl Acad Sci USA 105:15293\u201315298. https:\/\/doi.org\/10.1073\/pnas.0805837105","journal-title":"Proc Natl Acad Sci USA"},{"key":"10072_CR71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.virol.2012.05.010","volume":"432","author":"K Liu","year":"2012","unstructured":"Liu K, Feng X, Ma Z, Luo C, Zhou B, Cao R, Huang L, Miao D, Pang R, He D, Lian X, Chen P (2012) Antiviral activity of phage display selected peptides against Porcine reproductive and respiratory syndrome virus in vitro. Virology 432:73\u201380. https:\/\/doi.org\/10.1016\/j.virol.2012.05.010","journal-title":"Virology"},{"key":"10072_CR72","first-page":"905","volume":"49","author":"MZ Liu","year":"2014","unstructured":"Liu MZ, Yang Y, Zhang SX, Tang L, Wang HM, Chen CJ, Shen ZF, Cheng KD, Kong JQ, Wang W (2014) A cyclotide against influenza A H1N1 virus from Viola yedoensis. Yao xue xue bao. Acta Pharm Sin 49:905\u2013912","journal-title":"Acta Pharm Sin"},{"key":"10072_CR73","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.virol.2005.02.002","volume":"334","author":"C Lorin","year":"2005","unstructured":"Lorin C, Saidi H, Belaid A et al (2005) The antimicrobial peptide Dermaseptin S4 inhibits HIV-1 infectivity in vitro. Virology 334:264\u2013275. https:\/\/doi.org\/10.1016\/j.virol.2005.02.002","journal-title":"Virology"},{"key":"10072_CR74","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1021\/np100613p","volume":"74","author":"Z Lu","year":"2011","unstructured":"Lu Z, Van Wagoner RM, Harper MK, Baker HL, Hooper JNA, Bewley CA, Ireland CM (2011) Mirabamides E-H, HIV-Inhibitory Depsipeptides from the Sponge Stelletta clavosa. J Nat 74:185\u2013193. https:\/\/doi.org\/10.1021\/np100613p","journal-title":"J Nat"},{"key":"10072_CR75","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3892\/ijmm.2014.1670","volume":"33","author":"X Lu","year":"2014","unstructured":"Lu X, Yao M, Zhang JM, Yang J, Lei YF, Huang XJ, Jia ZS, Ma L, Lan HY, Xu ZK, Yin W (2014) Identification of peptides that bind hepatitis C virus envelope protein E2 and inhibit viral cellular entry from a phage-display peptide library. Int J Mol Med 33:1312\u20131318. https:\/\/doi.org\/10.3892\/ijmm.2014.1670","journal-title":"Int J Mol Med"},{"key":"10072_CR76","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1128\/aem.01639-15","volume":"81","author":"C Luo","year":"2015","unstructured":"Luo C, Liu X, Zhou X, Guo J, Truong J, Wang X, Zhou H, Li X, Chen Z (2015) Unusual biosynthesis and structure of locillomycins from Bacillus subtilis 916. Appl Environ Microbiol 81:6601\u20136609. https:\/\/doi.org\/10.1128\/aem.01639-15","journal-title":"Appl Environ Microbiol"},{"key":"10072_CR77","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/bip.21316","volume":"92","author":"CT Mant","year":"2009","unstructured":"Mant CT, Kovacs JM, Kim HM, Pollock DD, Hodges RS (2009) Intrinsic amino acid side-chain hydrophilicity\/hydrophobicity coefficients determined by reversed-phase high-performance liquid chromatography of model peptides: comparison with other hydrophilicity\/hydrophobicity scales. Biopolymers 92:573\u2013595. https:\/\/doi.org\/10.1002\/bip.21316","journal-title":"Biopolymers"},{"key":"10072_CR78","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.biochi.2008.05.016","volume":"91","author":"AK Marr","year":"2009","unstructured":"Marr AK, Jenssen H, Moniri MR, Hancock RE, Pant\u00e9 N (2009) Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1. Biochimie 91:160\u2013164. https:\/\/doi.org\/10.1016\/j.biochi.2008.05.016","journal-title":"Biochimie"},{"key":"10072_CR79","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/biom9090498","volume":"9","author":"M Mascini","year":"2019","unstructured":"Mascini M, Dikici E, Robles Ma\u00f1ueco M, Perez-Erviti JA, Deo SK, Compagnone D, Wang J, Pingarr\u00f3n JM, Daunert S (2019) Computationally designed peptides for Zika virus detection: an incremental construction approach. Biomolecules 9:498. https:\/\/doi.org\/10.3390\/biom9090498","journal-title":"Biomolecules"},{"key":"10072_CR80","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/740982","author":"T Matsubara","year":"2012","unstructured":"Matsubara T (2012) Potential of peptides as inhibitors and mimotopes: selection of carbohydrate-mimetic peptides from phage display libraries. J Nucleic Acids. https:\/\/doi.org\/10.1155\/2012\/740982","journal-title":"J Nucleic Acids"},{"key":"10072_CR81","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1021\/jm801570y","volume":"52","author":"T Matsubara","year":"2009","unstructured":"Matsubara T, Sumi M, Kubota H, Taki T, Okahata Y, Sato T (2009) Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. J Med Chem 52:4247\u20134256. https:\/\/doi.org\/10.1021\/jm801570y","journal-title":"J Med Chem"},{"key":"10072_CR82","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/hepr.12627","volume":"46","author":"T Matsumura","year":"2016","unstructured":"Matsumura T, Sugiyama N, Murayama A, Yamada N, Shiina M, Asabe S, Wakita T, Imawari M, Kato T (2016) Antimicrobial peptide LL-37 attenuates infection of hepatitis C virus. Hepatol Res 46:924\u2013932. https:\/\/doi.org\/10.1111\/hepr.12627","journal-title":"Hepatol Res"},{"key":"10072_CR83","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.micres.2016.12.002","volume":"196","author":"M Mei","year":"2017","unstructured":"Mei M, Zhou Y, Peng W, Yu C, Ma L, Zhang G, Yi L (2017) Application of modified yeast surface display technologies for non-Antibody protein engineering. Microbiol Res 196:118\u2013128. https:\/\/doi.org\/10.1016\/j.micres.2016.12.002","journal-title":"Microbiol Res"},{"key":"10072_CR84","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/j.1468-3083.2008.02675.x","volume":"22","author":"U Meyer-Hoffert","year":"2008","unstructured":"Meyer-Hoffert U, Schwarz T, Schroder J-M, Gl\u00e4ser R (2008) Expression of human beta-defensin-2 and -3 in verrucae vulgares and condylomata acuminata. J Eur Acad Dermatol Venereol 22:1050\u20131054. https:\/\/doi.org\/10.1111\/j.1468-3083.2008.02675.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10072_CR85","doi-asserted-by":"publisher","first-page":"e47047","DOI":"10.1371\/journal.pone.0047047","volume":"7","author":"L Migliolo","year":"2012","unstructured":"Migliolo L, Silva ON, Silva PA, Costa MP, Costa CR, Nolasco DO, Barbosa JA, Silva MR, Bemquerer MP, Lima LM, Romanos MT (2012) Structural and functional characterization of a multifunctional alanine-rich peptide analogue from pleuronectes americanus. PLoS ONE 7:e47047. https:\/\/doi.org\/10.1371\/journal.pone.0047047","journal-title":"PLoS ONE"},{"key":"10072_CR86","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.antiviral.2007.03.012","volume":"75","author":"N Mistry","year":"2007","unstructured":"Mistry N, Drobni P, N\u00e4slund J, Sunkari VG, Jenssen H, Evander M (2007) The anti-papillomavirus activity of human and bovine lactoferricin. Antiviral Res 75:258\u2013265. https:\/\/doi.org\/10.1016\/j.antiviral.2007.03.012","journal-title":"Antiviral Res"},{"key":"10072_CR87","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.virol.2017.11.009","volume":"514","author":"JMC Monteiro","year":"2018","unstructured":"Monteiro JMC, Oliveira MD, Dias RS, Nacif-Mar\u00e7al L, Feio RN, Ferreira SO, Oliveira LL, Silva CC, Paula SO (2018) The antimicrobial peptide HS-1 inhibits dengue virus infection. Virology 514:79\u201387. https:\/\/doi.org\/10.1016\/j.virol.2017.11.009","journal-title":"Virology"},{"key":"10072_CR88","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3390\/toxins7041126","volume":"7","author":"M Moreno","year":"2015","unstructured":"Moreno M, Giralt E (2015) Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan. Toxins 7:1126\u20131150. https:\/\/doi.org\/10.3390\/toxins7041126","journal-title":"Toxins"},{"key":"10072_CR89","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1039\/c4cc08565e","volume":"51","author":"L Nevola","year":"2015","unstructured":"Nevola L, Giralt E (2015) Modulating protein-protein interactions: the potential of peptides. Chem Commun (Camb) 51:3302\u20133315. https:\/\/doi.org\/10.1039\/c4cc08565e","journal-title":"Chem Commun (Camb)"},{"key":"10072_CR90","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1021\/acssynbio.9b00419","volume":"9","author":"M Newton","year":"2019","unstructured":"Newton M, Cabezas-Perusse Y, Tong CL, Seelig B (2019) In vitro selection of peptides and proteins\u2013advantages of mRNA display. ACS Synth Biol 9:181\u2013190. https:\/\/doi.org\/10.1021\/acssynbio.9b00419","journal-title":"ACS Synth Biol"},{"key":"10072_CR91","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1021\/np040003f","volume":"67","author":"N Oku","year":"2004","unstructured":"Oku N, Gustafson KR, Cartner LK, Wilson JA, Shigematsu N, Hess S, Pannell LK, Boyd MR, McMahon JB (2004) Neamphamide A, a new HIV-inhibitory depsipeptide from the papua new guinea marine sponge Neamphius huxleyi. J Nat 67:1407\u20131411. https:\/\/doi.org\/10.1021\/np040003f","journal-title":"J Nat"},{"key":"10072_CR92","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1292\/jvms.67.1237","volume":"67","author":"M Ozawa","year":"2005","unstructured":"Ozawa M, Ohashi K, Onuma M (2005) Identification and characterization of peptides binding to newcastle disease virus by phage display. J Vet Med Sci 67:1237\u20131241. https:\/\/doi.org\/10.1292\/jvms.67.1237","journal-title":"J Vet Med Sci"},{"key":"10072_CR93","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/cbdd.13400","volume":"93","author":"A Panya","year":"2019","unstructured":"Panya A, Yongpitakwattana P, Budchart P, Sawasdee N, Krobthong S, Paemanee A, Roytrakul S, Rattanabunyong S, Choowongkomon K, Yenchitsomanus P (2019) Novel bioactive peptides demonstrating anti-dengue virus activity isolated from the Asian medicinal plant Acacia Catechu. Chem Biol Drug Des 93:100\u2013109. https:\/\/doi.org\/10.1111\/cbdd.13400","journal-title":"Chem Biol Drug Des"},{"key":"10072_CR94","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bbamem.2013.04.028","volume":"1838","author":"SG Patching","year":"2014","unstructured":"Patching SG (2014) Surface plasmon resonance spectroscopy for characterization of membrane protein\u2013ligand interactions and its potential for drug discovery. Biochim Biophys Acta 1838:43\u201355. https:\/\/doi.org\/10.1016\/j.bbamem.2013.04.028","journal-title":"Biochim Biophys Acta"},{"key":"10072_CR95","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11427-006-0158-7","volume":"49","author":"B Peng","year":"2006","unstructured":"Peng B, Chen H, Tan Y, Jin M, Chen H, Guo A (2006) Identification of one peptide which inhibited infectivity of avian infectious bronchitis virus in vitro. Sci China C 49:8. https:\/\/doi.org\/10.1007\/s11427-006-0158-7","journal-title":"Sci China C"},{"key":"10072_CR96","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1021\/np070306k","volume":"70","author":"A Plaza","year":"2007","unstructured":"Plaza A, Gustchina E, Baker HL, Kelly M, Bewley CA (2007) Mirabamides A-D, Depsipeptides from the Sponge Siliquariaspongia mirabilis that inhibit HIV-1 Fusion. J Nat Prod 70:1753\u20131760. https:\/\/doi.org\/10.1021\/np070306k","journal-title":"J Nat Prod"},{"key":"10072_CR97","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1021\/jo802232u","volume":"74","author":"A Plaza","year":"2009","unstructured":"Plaza A, Bifulco G, Keffer JL, Lloyd JR, Baker HL, Bewley CA (2009) Celebesides A-C and theopapuamides B-D, depsipeptides from an Indonesian sponge that inhibit HIV-1 entry. J Org Chem 74:504\u2013512. https:\/\/doi.org\/10.1021\/jo802232u","journal-title":"J Org Chem"},{"key":"10072_CR98","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1021\/jo100076g","volume":"75","author":"A Plaza","year":"2010","unstructured":"Plaza A, Bifulco G, Masullo M, Lloyd JR, Keffer JL, Colin PL, Hooper JN, Bell LJ, Bewley CA (2010) Mutremdamide A and koshikamides C-H, peptide inhibitors of HIV-1 entry from different Theonella species. J Org Chem 75:4344\u20134355. https:\/\/doi.org\/10.1021\/jo100076g","journal-title":"J Org Chem"},{"key":"10072_CR99","doi-asserted-by":"publisher","first-page":"F39","DOI":"10.1097\/01.aids.0000096878.73209.4f","volume":"17","author":"ME Quinones-Mateu","year":"2003","unstructured":"Quinones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel HR, Marotta ML, Mirza M, Jiang B, Kiser P, Medvik K (2003) Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 17:F39\u2013F48. https:\/\/doi.org\/10.1097\/01.aids.0000096878.73209.4f","journal-title":"AIDS"},{"key":"10072_CR100","doi-asserted-by":"publisher","first-page":"D1147","DOI":"10.1093\/nar\/gkt1191","volume":"42","author":"A Qureshi","year":"2013","unstructured":"Qureshi A, Thakur N, Himani T, Kumar M (2013) AVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses. Nucl Acids Res 42:D1147\u2013D1153. https:\/\/doi.org\/10.1093\/nar\/gkt1191","journal-title":"Nucl Acids Res"},{"key":"10072_CR101","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1743-422X-6-74","volume":"6","author":"M Rajik","year":"2009","unstructured":"Rajik M, Jahanshiri F, Omar AR, Ideris A, Hassan SS, Yusoff K (2009) Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2. Virol J 6:74. https:\/\/doi.org\/10.1186\/1743-422X-6-74","journal-title":"Virol J"},{"key":"10072_CR102","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00705-001-0778-y","volume":"147","author":"P Ramanujam","year":"2002","unstructured":"Ramanujam P, Tan WS, Nathan S, Yusoff K (2002) Novel peptides that inhibit the propagation of Newcastle disease virus. Arch Virol 147:981\u2013993. https:\/\/doi.org\/10.1007\/s00705-001-0778-y","journal-title":"Arch Virol"},{"key":"10072_CR103","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1021\/np0002379","volume":"64","author":"MA Rashid","year":"2001","unstructured":"Rashid MA, Gustafson KR, Cartner LK, Shigematsu N, Pannell LK, Boyd MR (2001) Microspinosamide, a new HIV-inhibitory cyclic depsipeptide from the marine sponge Sidonops microspinosa. J Nat Prod 64:117\u2013121. https:\/\/doi.org\/10.1021\/np0002379","journal-title":"J Nat Prod"},{"key":"10072_CR104","doi-asserted-by":"publisher","first-page":"e22572","DOI":"10.1371\/journal.pone.0022572","volume":"6","author":"TH Rider","year":"2011","unstructured":"Rider TH, Zook CE, Boettcher TL, Wick ST, Pancoast JS, Zusman BD (2011) Broad-spectrum antiviral therapeutics. PLoS ONE 6:e22572. https:\/\/doi.org\/10.1371\/journal.pone.0022572","journal-title":"PLoS ONE"},{"key":"10072_CR105","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/jlb.63.1.94","volume":"63","author":"WE Robinson","year":"1998","unstructured":"Robinson WE, McDougall B, Tran D, Selsted ME (1998) Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils. J Leukoc Biol 63:94\u2013100. https:\/\/doi.org\/10.1002\/jlb.63.1.94","journal-title":"J Leukoc Biol"},{"key":"10072_CR106","doi-asserted-by":"publisher","first-page":"e39911","DOI":"10.1371\/journal.pone.0039911","volume":"7","author":"MS Rogers","year":"2012","unstructured":"Rogers MS, Cryan LM, Habeshian KA, Bazinet L, Caldwell TP, Ackroyd PC, Christensen KA (2012) A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein. PLoS ONE 7:e39911. https:\/\/doi.org\/10.1371\/journal.pone.0039911","journal-title":"PLoS ONE"},{"key":"10072_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/251482","volume":"2012","author":"HA Rothan","year":"2012","unstructured":"Rothan HA, Abdulrahman AY, Sasikumer PG, Othman S, Abd Rahman N, Yusof R (2012) Protegrin-1 inhibits dengue NS2B-NS3 serine protease and viral replication in MK2 cells. J Biomed Biotechnol 2012:1\u20136. https:\/\/doi.org\/10.1155\/2012\/251482","journal-title":"J Biomed Biotechnol"},{"key":"10072_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-14-140","volume":"14","author":"HA Rothan","year":"2014","unstructured":"Rothan HA, Bahrani H, Rahman NA, Yusof R (2014) Identification of natural antimicrobial agents to treat dengue infection: in vitro analysis of latarcin peptide activity against dengue virus. BMC Microbiol 14:1\u201310. https:\/\/doi.org\/10.1186\/1471-2180-14-140","journal-title":"BMC Microbiol"},{"key":"10072_CR109","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1086\/521027","volume":"196","author":"M Salvatore","year":"2007","unstructured":"Salvatore M, Garc\u00eda-Sastre A, Ruchala P, Lehrer RI, Chang T, Klotman ME (2007) \u03b1-defensin inhibits influenza virus replication by cell-mediated mechanism(s). J Infect Dis 196:835\u2013843. https:\/\/doi.org\/10.1086\/521027","journal-title":"J Infect Dis"},{"key":"10072_CR110","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.peptides.2013.07.014","volume":"48","author":"CJ Sample","year":"2013","unstructured":"Sample CJ, Hudak KE, Barefoot BE, Koci MD, Wanyonyi MS, Abraham S, Staats HF, Ramsburg EA (2013) A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses. Peptides 48:96\u2013105. https:\/\/doi.org\/10.1016\/j.peptides.2013.07.014","journal-title":"Peptides"},{"key":"10072_CR111","doi-asserted-by":"publisher","first-page":"e0007419","DOI":"10.1371\/journal.pntd.0007419","volume":"13","author":"N Sen","year":"2019","unstructured":"Sen N, Kanitkar TR, Roy AA, Soni N, Amritkar K, Supekar S, Nair S, Singh G, Madhusudhan M (2019) Predicting and Designing therapeutics against the Nipah virus. PLoS Negl Trop Dis 13:e0007419. https:\/\/doi.org\/10.1371\/journal.pntd.0007419","journal-title":"PLoS Negl Trop Dis"},{"key":"10072_CR112","doi-asserted-by":"publisher","first-page":"5573","DOI":"10.2174\/1381612821666151002113426","volume":"21","author":"M Sencanski","year":"2015","unstructured":"Sencanski M, Radosevic D, Perovic V, Gemovic B, Stanojevic M, Veljkovic N, Glisic S (2015) Natural products as promising therapeutics for treatment of influenza disease. Curr Pharm Des 21:5573\u20135588. https:\/\/doi.org\/10.2174\/1381612821666151002113426","journal-title":"Curr Pharm Des"},{"key":"10072_CR113","doi-asserted-by":"publisher","first-page":"e51383","DOI":"10.3791\/51383","volume":"18","author":"NB Shah","year":"2014","unstructured":"Shah NB, Duncan TM (2014) Bio-layer interferometry for measuring kinetics of protein-protein interactions and allosteric ligand effects. J Vis Exp 18:e51383. https:\/\/doi.org\/10.3791\/51383","journal-title":"J Vis Exp"},{"key":"10072_CR114","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1016\/j.tetlet.2015.05.058","volume":"56","author":"HJ Shin","year":"2015","unstructured":"Shin HJ, Rashid MA, Cartner LK, Bokesch HR, Wilson JA, McMahon JB, Gustafson KR (2015) Stellettapeptins A and B, HIV-inhibitory cyclic depsipeptides from the marine sponge Stelletta sp. Tetrahedron Lett 56:4215\u20134219. https:\/\/doi.org\/10.1016\/j.tetlet.2015.05.058","journal-title":"Tetrahedron Lett"},{"key":"10072_CR115","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.3390\/v7102883","volume":"7","author":"S Skalickova","year":"2015","unstructured":"Skalickova S, Heger Z, Krejcova L, Pekarik V, Bastl K, Janda J, Kostolansky F, Vareckova E, Zitka O, Adam V, Kizek R (2015) Perspective of use of antiviral peptides against influenza virus. Viruses 7:5428\u20135442. https:\/\/doi.org\/10.3390\/v7102883","journal-title":"Viruses"},{"key":"10072_CR116","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1182\/blood.v97.12.3951","volume":"97","author":"OE S\u00f8rensen","year":"2001","unstructured":"S\u00f8rensen OE, Follin P, Johnsen AH et al (2001) Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97:3951\u20133959. https:\/\/doi.org\/10.1182\/blood.v97.12.3951","journal-title":"Blood"},{"key":"10072_CR117","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.peptides.2017.07.013","volume":"95","author":"FH Sousa","year":"2017","unstructured":"Sousa FH, Casanova V, Findlay F, Stevens C, Svoboda P, Pohl J, Proudfoot L, Barlow PG (2017) Cathelicidins display conserved direct antiviral activity towards rhinovirus. Peptides 95:76\u201383. https:\/\/doi.org\/10.1016\/j.peptides.2017.07.013","journal-title":"Peptides"},{"key":"10072_CR118","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/1471-2180-11-160","volume":"11","author":"EC Sun","year":"2011","unstructured":"Sun EC, Ma JN, Liu NH, Yang T, Zhao J, Geng HW, Wang LF, Qin YL, Bu ZG, Yang YH, Lunt RA, Wang LF, Wu DL (2011) Identification of two linear B-cell epitopes from West Nile virus NS1 by screening a phage-displayed random peptide library. BMC Microbiol 11:160. https:\/\/doi.org\/10.1186\/1471-2180-11-160","journal-title":"BMC Microbiol"},{"key":"10072_CR119","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/ed100186y","volume":"87","author":"Y Tang","year":"2010","unstructured":"Tang Y, Zeng X, Liang J (2010) Surface plasmon resonance: an introduction to a surface spectroscopy technique. J Chem Educ 87:742\u2013746. https:\/\/doi.org\/10.1021\/ed100186y","journal-title":"J Chem Educ"},{"key":"10072_CR120","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/molecules16010221","volume":"16","author":"E Teissier","year":"2011","unstructured":"Teissier E, Penin F, P\u00e9cheur EI (2011) Targeting cell entry of enveloped viruses as an antiviral strategy. Molecules 16:221\u2013250. https:\/\/doi.org\/10.3390\/molecules16010221","journal-title":"Molecules"},{"key":"10072_CR121","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.bmc.2017.07.064","volume":"26","author":"RL Tennyson","year":"2018","unstructured":"Tennyson RL, Walker SN, Ikeda T, Harris RS, McNaughton BR (2018) Evaluation of sequence variability in HIV-1 gp41 C-peptide helix-grafted proteins. Bioorg Med Chem 26:1220\u20131224. https:\/\/doi.org\/10.1016\/j.bmc.2017.07.064","journal-title":"Bioorg Med Chem"},{"key":"10072_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0124706","volume":"10","author":"S Tripathi","year":"2015","unstructured":"Tripathi S, Wang G, White M, Qi L, Taubenberger J, Hartshorn KL (2015) Antiviral activity of the human cathelicidin, LL-37, and derived peptides on seasonal and pandemic influenza A viruses. PLoS ONE 10:1\u201317. https:\/\/doi.org\/10.1371\/journal.pone.0124706","journal-title":"PLoS ONE"},{"key":"10072_CR123","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/s0166-3542(01)00195-4","volume":"52","author":"BWA Van der Strate","year":"2001","unstructured":"Van der Strate BWA, Beljaars L, Molema G, Harmsen MC, Meijer DKF (2001) Antiviral activities of lactoferrin. Antiviral Res 52:225\u2013239. https:\/\/doi.org\/10.1016\/s0166-3542(01)00195-4","journal-title":"Antiviral Res"},{"key":"10072_CR124","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1099\/0022-1317-79-4-731","volume":"79","author":"M Wachinger","year":"1998","unstructured":"Wachinger M, Kleinschmidt A, Winder D, von Pechmann N, Ludvigsen A, Neumann M, Holle R, Salmons B, Erfle V, Brack-Werner R (1998) Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J Gen Virol 79:731\u2013740. https:\/\/doi.org\/10.1099\/0022-1317-79-4-731","journal-title":"J Gen Virol"},{"key":"10072_CR125","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1586\/epr.11.15","volume":"8","author":"H Wang","year":"2011","unstructured":"Wang H, Liu R (2011) Advantages of mRNA display selections over other selection techniques for investigaiu Rtion of protein\u2013protein interactions. Expert Rev Proteomic 8:335\u2013346. https:\/\/doi.org\/10.1586\/epr.11.15","journal-title":"Expert Rev Proteomic"},{"key":"10072_CR126","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1021\/np070393g","volume":"71","author":"CKL Wang","year":"2008","unstructured":"Wang CKL, Colgrave ML, Gustafson KR, Ireland DC, Goransson U, Craik DJ (2008) Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis. J Nat Prod 71:47\u201352. https:\/\/doi.org\/10.1021\/np070393g","journal-title":"J Nat Prod"},{"key":"10072_CR127","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bbrc.2011.08.014","volume":"412","author":"W Wang","year":"2011","unstructured":"Wang W, Liu Y, Zu X, Jin R, Xiao G (2011) Blocking peptides against HBV: PreS1 protein selected from a phage display library. Biochem Biophys Res Commun 412:633\u2013637. https:\/\/doi.org\/10.1016\/j.bbrc.2011.08.014","journal-title":"Biochem Biophys Res Commun"},{"key":"10072_CR128","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1007\/s12010-016-2059-y","volume":"179","author":"WY Wang","year":"2016","unstructured":"Wang WY, Wong JH, Ip DT, Wan DC, Cheung RC, Ng TB (2016) Bovine lactoferrampin, human lactoferricin, and lactoferrin 1\u201311 inhibit nuclear translocation of HIV integrase. Appl Biochem Biotechnol 179:1202\u20131212. https:\/\/doi.org\/10.1007\/s12010-016-2059-y","journal-title":"Appl Biochem Biotechnol"},{"key":"10072_CR129","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.3390\/molecules22112037","volume":"22","author":"CK Wang","year":"2017","unstructured":"Wang CK, Shih LY, Chang K (2017) Large-scale analysis of antimicrobial activities in relation to amphipathicity and charge reveals novel characterization of antimicrobial peptides. Molecules 22:2037. https:\/\/doi.org\/10.3390\/molecules22112037","journal-title":"Molecules"},{"key":"10072_CR130","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10822-011-9439-8","volume":"25","author":"CA Wartchow","year":"2011","unstructured":"Wartchow CA, Podlaski F, Li S, Rowan K, Zhang X, Mark D, Huang KS (2011) Biosensor-based small molecule fragment screening with biolayer interferometry. J Comput Aided Mol Des 25:669\u2013676. https:\/\/doi.org\/10.1007\/s10822-011-9439-8","journal-title":"J Comput Aided Mol Des"},{"key":"10072_CR131","doi-asserted-by":"publisher","first-page":"104673","DOI":"10.1016\/j.antiviral.2019.104673","volume":"174","author":"J Wei","year":"2019","unstructured":"Wei J, Hameed M, Wang X, Zhang J, Guo S, Anwar MN, Pang L, Liu K, Li B, Shao D, Qiu Y (2019) Antiviral activity of phage display-selected peptides against Japanese encephalitis virus infection in vitro and in vivo. Antiviral Res 174:104673. https:\/\/doi.org\/10.1016\/j.antiviral.2019.104673","journal-title":"Antiviral Res"},{"key":"10072_CR132","doi-asserted-by":"publisher","first-page":"4801","DOI":"10.1093\/jxb\/erw210","volume":"67","author":"J Weidmann","year":"2016","unstructured":"Weidmann J, Craik DJ (2016) Discovery, structure, function, and applications of cyclotides: circular proteins from plants. J Exp Bot 67:4801\u20134812. https:\/\/doi.org\/10.1093\/jxb\/erw210","journal-title":"J Exp Bot"},{"key":"10072_CR133","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.febslet.2004.11.062","volume":"579","author":"Z Wu","year":"2005","unstructured":"Wu Z, Cocchi F, Gentles D, Ericksen B, Lubkowski J, DeVico A, Lehrer RI, Lu W (2005) Human neutrophil \u03b1-defensin 4 inhibits HIV-1 infection in vitro. FEBS Lett 579:162\u2013166. https:\/\/doi.org\/10.1016\/j.febslet.2004.11.062","journal-title":"FEBS Lett"},{"key":"10072_CR134","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/protein\/gzq037","volume":"23","author":"SJ Wu","year":"2010","unstructured":"Wu SJ, Luo J, O'Neil KT, Kang J, Lacy ER, Canziani G, Baker A, Huang M, Tang QM, Raju TS, Jacobs SA (2010) Structure-based engineering of a monoclonal antibody for improved solubility. Protein Eng Des Sel 23:643\u2013651. https:\/\/doi.org\/10.1093\/protein\/gzq037","journal-title":"Protein Eng Des Sel"},{"key":"10072_CR135","doi-asserted-by":"publisher","first-page":"e23058","DOI":"10.1371\/journal.pone.0023058","volume":"6","author":"D Wu","year":"2011","unstructured":"Wu D, Li G, Qin C, Ren X (2011) Phage displayed peptides to avian H5N1 virus distinguished the virus from other viruses. PLoS ONE 6:e23058. https:\/\/doi.org\/10.1371\/journal.pone.0023058","journal-title":"PLoS ONE"},{"key":"10072_CR136","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.peptides.2010.10.008","volume":"32","author":"R Yan","year":"2011","unstructured":"Yan R, Zhao Z, He Y, Wu L, Cai D, Hong W, Wu Y, Cao Z, Zheng C, Li W (2011) A new natural \u03b1-helical peptide from the venom of the scorpion Heterometrus petersii kills HCV. Peptides 32:11\u201319. https:\/\/doi.org\/10.1016\/j.peptides.2010.10.008","journal-title":"Peptides"},{"key":"10072_CR137","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.antiviral.2014.06.012","volume":"109","author":"L Yin","year":"2014","unstructured":"Yin L, Luo Y, Liang B, Wang F, Du M, Petrenko VA, Qiu HJ, Liu A (2014) Specific ligands for classical swine fever virus screened from landscape phage display library. Antivir Res 109:68\u201371. https:\/\/doi.org\/10.1016\/j.antiviral.2014.06.012","journal-title":"Antivir Res"},{"key":"10072_CR138","doi-asserted-by":"publisher","first-page":"12703","DOI":"10.1074\/jbc.ra118.003538","volume":"293","author":"D Yu","year":"2018","unstructured":"Yu D, Ding X, Liu Z, Wu X, Zhu Y, Wei H, Chong H, Cui S, He Y (2018) Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial\u2013approved membrane fusion inhibitor. J Biol Chem 293:12703\u201312718. https:\/\/doi.org\/10.1074\/jbc.ra118.003538","journal-title":"J Biol Chem"},{"key":"10072_CR139","doi-asserted-by":"publisher","first-page":"e0215227","DOI":"10.1371\/journal.pone.0215227","volume":"14","author":"L Yuan","year":"2019","unstructured":"Yuan L, Zhang S, Peng J, Li Y, Yang Q (2019) Synthetic surfactin analogues have improved anti-PEDV properties. PLoS ONE 14:e0215227. https:\/\/doi.org\/10.1371\/journal.pone.0215227","journal-title":"PLoS ONE"},{"key":"10072_CR140","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nmeth1003","volume":"4","author":"C Zahnd","year":"2007","unstructured":"Zahnd C, Amstutz P, Pl\u00fcckthun A (2007) Ribosome display: selecting and evolving proteins in vitro that specifically binds to a target. Nat Methods 4:269\u2013279. https:\/\/doi.org\/10.1038\/nmeth1003","journal-title":"Nat Methods"},{"key":"10072_CR141","doi-asserted-by":"publisher","first-page":"6202","DOI":"10.1021\/ja954287p","volume":"118","author":"A Zampella","year":"1996","unstructured":"Zampella A, D\u2019Auria MV, Paloma LG, Casapullo A, Minale L, Debitus C, Henin Y (1996) Callipeltin A, an anti-hiv cyclic depsipeptide from the new caledonian lithistida sponge Callipelta sp. J Am Chem Soc 118:6202\u20136209. https:\/\/doi.org\/10.1021\/ja954287p","journal-title":"J Am Chem Soc"},{"issue":"14","key":"10072_CR142","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1021\/jo800583b","volume":"73","author":"A Zampella","year":"2008","unstructured":"Zampella A, Sepe V, Luciano P, Bellotta F, Monti MC, D\u2019Auria MV, Jepsen T, Petek S, Adeline MT, Lapr\u00e9v\u00f4te O, Aubertin AM (2008) Homophymine A, an anti-HIV cyclodepsipeptide from the sponge Homophymia sp. J Org Chem 73(14):5319\u20135327. https:\/\/doi.org\/10.1021\/jo800583b","journal-title":"J Org Chem"},{"key":"10072_CR143","doi-asserted-by":"publisher","first-page":"199","DOI":"10.7150\/thno.21425","volume":"8","author":"Z Zeng","year":"2018","unstructured":"Zeng Z, Zhang R, Hong W, Cheng Y, Wang H, Lang Y, Ji Z, Wu Y, Li W, Xie Y, Cao Z (2018) Histidine-rich modification of a scorpion-derived peptide improves bioavailability and inhibitory activity against HSV-1. Theranostics 8:199\u2013211. https:\/\/doi.org\/10.7150\/thno.21425","journal-title":"Theranostics"},{"key":"10072_CR144","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.dci.2018.10.005","volume":"91","author":"S Zhan","year":"2018","unstructured":"Zhan S, Aweya JJ, Wang F, Yao D, Zhong M, Chen J, Li S, Zhang Y (2018) Litopenaeus vannamei attenuates white spot syndrome virus replication by specific antiviral peptides generated from hemocyanin. Dev Comp Immunol 91:50\u201361. https:\/\/doi.org\/10.1016\/j.dci.2018.10.005","journal-title":"Dev Comp Immunol"},{"key":"10072_CR145","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1016\/j.cub.2015.11.017","volume":"26","author":"LJ Zhang","year":"2016","unstructured":"Zhang LJ, Gallo RL (2016) Antimicrobial peptides. Curr Biol 26:R14\u2013R19. https:\/\/doi.org\/10.1016\/j.cub.2015.11.017","journal-title":"Curr Biol"},{"key":"10072_CR146","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00284-012-0284-3","volume":"66","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, Wang Y, Ji Q, Gu J, Liu S, Feng X, Sun C, Li Y, Lei L (2012) Selection of antiviral peptides against mink enteritis virus using a phage display peptide library. Curr Microbiol 66:379\u2013384. https:\/\/doi.org\/10.1007\/s00284-012-0284-3","journal-title":"Curr Microbiol"},{"key":"10072_CR147","doi-asserted-by":"publisher","first-page":"30181","DOI":"10.1074\/jbc.m112.370312","volume":"287","author":"Z Zhao","year":"2012","unstructured":"Zhao Z, Hong W, Zeng Z, Wu Y, Hu K, Tian X, Li W, Cao Z (2012) Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4\u03b1 in vitro and in vivo. J Biol Chem 287:30181\u201330190. https:\/\/doi.org\/10.1074\/jbc.m112.370312","journal-title":"J Biol Chem"},{"key":"10072_CR148","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.antiviral.2014.01.011","volume":"104","author":"X Zu","year":"2014","unstructured":"Zu X, Liu Y, Wang S, Jin R, Zhou Z, Liu H, Gong R, Xiao G, Wang W (2014) Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III. Antiviral Res 104:7\u201314. https:\/\/doi.org\/10.1016\/j.antiviral.2014.01.011","journal-title":"Antiviral Res"}],"container-title":["International Journal of Peptide Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10989-020-10072-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10989-020-10072-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10989-020-10072-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:47:28Z","timestamp":1744177648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10989-020-10072-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10072"],"URL":"https:\/\/doi.org\/10.1007\/s10989-020-10072-0","relation":{},"ISSN":["1573-3149","1573-3904"],"issn-type":[{"value":"1573-3149","type":"print"},{"value":"1573-3904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,18]]},"assertion":[{"value":"13 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest in the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This is a review article which does not contain any type of studies related to human or animal participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}